What is the prevalence of Ollier disease?

Ollier disease is a rare, non-hereditary condition characterized by multiple enchondromas, with an estimated prevalence of approximately 1 in 100,000 people. While exact incidence is difficult to determine due to underdiagnosis, the condition typically presents in early childhood and affects males and females with roughly equal frequency.

Is Ollier disease considered a rare condition?

Yes, Ollier disease is classified as a rare condition. Because it is a sporadic disorder—meaning it is not typically passed down through families—it does not follow the predictable patterns of common genetic diseases. Current medical literature, including data from Orphanet, estimates the prevalence of Ollier disease at approximately 1 in 100,000 individuals. However, experts believe the true prevalence may be higher, as mild or asymptomatic cases often go undiagnosed or are only discovered incidentally during imaging for unrelated issues.

What is the typical age of onset and gender distribution?

Ollier disease is primarily a pediatric-onset condition. Symptoms usually manifest within the first decade of life, often between the ages of 1 and 10. While the physical manifestations, such as limb length discrepancy or bony deformities, may become more apparent as a child grows, the underlying cartilaginous tumors (enchondromas) are often present from birth or early infancy. Clinical studies indicate that Ollier disease affects males and females with equal frequency, showing no significant gender predilection in its occurrence.

What challenges exist in gathering accurate data?

Determining the exact number of people living with Ollier disease is challenging for several reasons:

• Asymptomatic presentation: Many individuals with fewer or smaller enchondromas may never experience pain or deformity, leading to a lack of clinical reporting.


• Diagnostic overlap: Ollier disease is often confused with Maffucci syndrome, a related but distinct condition that involves both enchondromas and hemangiomas.


• Lack of specialized registries: Because the condition is rare, there is no universal global registry, making it difficult to track every patient.


• Real-world insights: Our platform, DiseaseMaps.org, currently supports 279 people with Ollier disease. This community data provides a vital, real-world perspective that complements traditional clinical literature by highlighting the lived experiences of those who may not be captured in formal hospital-based prevalence studies.

Are there geographic or ethnic variations in prevalence?

There is no evidence in current medical literature suggesting that Ollier disease has a higher prevalence in specific geographic regions or ethnic populations. Because the condition is caused by post-zygotic somatic mutations (specifically in the IDH1 or IDH2 genes), it occurs randomly across all demographics. Researchers have not identified any environmental or ethnic triggers that would increase the risk of developing this condition.

Next steps

• Consult with an orthopedic oncologist or a pediatric orthopedist if you notice bone deformities or persistent pain.


• Request a referral to a genetic counselor to discuss the nature of somatic mutations in Ollier disease.


• Connect with the 279 members of the DiseaseMaps.org community to share experiences and learn about ongoing clinical management strategies.


• Maintain regular follow-up imaging (such as X-rays or MRIs) as recommended by your physician to monitor the growth and behavior of enchondromas.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment from a qualified healthcare provider.

References

• Orphanet: Rare disease database (ORPHA:657)


• NIH Genetic and Rare Diseases Information Center (GARD)


• OMIM (Online Mendelian Inheritance in Man): Entry #166000


• Journal of Bone and Joint Surgery: Clinical reviews on enchondromatosis